| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,726 |
10,127 |
$1.51M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,502 |
4,291 |
$833K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
642 |
632 |
$319K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
896 |
864 |
$268K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,446 |
2,341 |
$196K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
395 |
385 |
$148K |
| 70450 |
Computed tomography, head or brain; without contrast material |
362 |
345 |
$63K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,556 |
1,483 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,327 |
1,249 |
$938.99 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
70 |
66 |
$433.55 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
412 |
398 |
$297.39 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
325 |
318 |
$172.55 |
| 87631 |
|
568 |
560 |
$135.67 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
965 |
930 |
$113.04 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,966 |
1,873 |
$113.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
888 |
866 |
$93.14 |
| 71045 |
Radiologic examination, chest; single view |
1,132 |
1,112 |
$88.35 |
| 80053 |
Comprehensive metabolic panel |
3,054 |
2,873 |
$81.92 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,041 |
1,029 |
$64.12 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
250 |
245 |
$51.31 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,124 |
2,982 |
$38.11 |
| 73630 |
|
147 |
138 |
$34.74 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,861 |
1,756 |
$27.86 |
| 71046 |
Radiologic examination, chest; 2 views |
585 |
573 |
$27.47 |
| 81003 |
|
2,046 |
1,969 |
$23.26 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
313 |
304 |
$21.43 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,140 |
2,014 |
$20.22 |
| 84484 |
|
607 |
579 |
$18.60 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,251 |
1,200 |
$18.39 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
184 |
182 |
$18.05 |
| 81025 |
|
1,539 |
1,484 |
$14.74 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
315 |
295 |
$13.97 |
| J3490 |
Unclassified drugs |
1,000 |
927 |
$6.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
125 |
116 |
$5.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,175 |
1,142 |
$4.75 |
| 82803 |
|
158 |
148 |
$0.00 |
| 80051 |
|
151 |
146 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,379 |
3,226 |
$0.00 |
| 85379 |
|
138 |
135 |
$0.00 |
| 83605 |
|
161 |
148 |
$0.00 |
| 87428 |
|
74 |
74 |
$0.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
382 |
311 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
104 |
87 |
$0.00 |
| 87480 |
|
14 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
421 |
407 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
113 |
112 |
$0.00 |
| 82550 |
|
151 |
146 |
$0.00 |
| 82553 |
|
232 |
221 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
92 |
89 |
$0.00 |
| 93971 |
|
13 |
12 |
$0.00 |
| 82962 |
|
12 |
12 |
$0.00 |
| 87510 |
|
14 |
14 |
$0.00 |
| 73130 |
|
103 |
99 |
$0.00 |
| 84702 |
|
262 |
253 |
$0.00 |
| 82947 |
|
77 |
75 |
$0.00 |
| 87660 |
|
14 |
14 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
242 |
234 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
258 |
254 |
$0.00 |
| 82565 |
|
78 |
75 |
$0.00 |
| 73610 |
|
137 |
127 |
$0.00 |
| 90715 |
|
112 |
111 |
$0.00 |
| 84520 |
|
78 |
75 |
$0.00 |
| 93976 |
|
12 |
12 |
$0.00 |
| 73030 |
|
13 |
12 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$0.00 |